Skip to content
777 Sourcing.

Capability

repurposing and optimizing calcium channel blockers

Suppliers
1
States & provinces
1
Countries
1

1 repurposing and optimizing calcium channel blockers supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

AISA PHARMA, INC.

BOSTON, MA

Aisa Pharma is a privately held, clinical-stage biopharmaceutical development company dedicated to bringing new disease-modifying treatments to patients with rare serious diseases. It focuses on repurposing and optimizing select calcium channel blockers, and its lead program is developing AISA-021, an oral therapy targeting N-type calcium channels for Raynaud's phenomenon associated with systemic sclerosis (scleroderma). The company is headquartered in Boston, Massachusetts, with additional presence in Sydney, Australia.

clinical developmentclinical operationsCMCdrug developmentRegulatory Affairs

Compiled from public sources

Related capabilities

Other processes offered by the shops that list repurposing and optimizing calcium channel blockers.

Browse all capabilities